Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.98 EUR | -5.10% | -0.67% | -8.02% |
2023 | Encres Dubuit Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Encres Dubuit Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The stock, which is currently worth 2023 to 0.3 times its sales, is clearly overvalued in comparison with peers.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.02% | 10.2M | - | ||
+5.18% | 1.75B | B+ | ||
+5.41% | 979M | D+ | ||
+9.13% | 966M | - | ||
+64.31% | 752M | - | - | |
-2.47% | 692M | - | - | |
+29.53% | 600M | B- | ||
-2.18% | 553M | - | ||
+15.68% | 499M | - | ||
-0.72% | 424M | - | D+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- ALDUB Stock
- Ratings Encres DUBUIT